We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.54%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.98B
AUM Growth
-$196M
Cap. Flow
-$412M
Cap. Flow %
-10.36%
Top 10 Hldgs %
19.57%
Holding
657
New
219
Increased
86
Reduced
120
Closed
218

Top Sells

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$129M
2
AMZN icon
Amazon
AMZN
+$79.3M
3
PYPL icon
PayPal
PYPL
+$57.7M
4
BRBR icon
BellRing Brands
BRBR
+$43.9M
5
TDG icon
TransDigm Group
TDG
+$41.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.78%
2 Communication Services 10.92%
3 Technology 9.79%
4 Healthcare 8.27%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLV icon
401
iShares Silver Trust
SLV
$28.8B
$339K 0.01%
+8,000
New +$287K
CNTA
402
DELISTED
Centessa Pharmaceuticals
CNTA
$318K 0.01%
13,105
-20,079
-61% -$357K
VTV icon
403
Vanguard Morningstar Value ETF
VTV
$191B
$315K 0.01%
+1,688
New +$306K
NKE icon
404
Nike
NKE
$61.6B
$295K 0.01%
+4,226
New +$315K
ARDX icon
405
CALL
Ardelyx
ARDX
$1.23B
$289K 0.01%
+52,500
New +$285K
AAL icon
406
PUT
American Airlines Group
AAL
$10.9B
$283K 0.01%
25,200
-847,500
-97% -$10.4M
REPL icon
407
CALL
Replimune Group
REPL
$1.01B
$283K 0.01%
67,600
DKNG icon
408
DraftKings
DKNG
$11.6B
$281K 0.01%
+7,517
New +$333K
MLTX icon
409
CALL
MoonLake Immunotherapeutics
MLTX
$1.52B
$267K 0.01%
37,200
+27,200
+272% +$1.42M
NUVL
410
DELISTED
Nuvalent
NUVL
$254K 0.01%
2,936
+236
+9% +$18.7K
HOOD icon
411
Robinhood
HOOD
$83.3B
$251K 0.01%
1,750
-1,962
-53% -$214K
TNGX icon
412
Tango Therapeutics
TNGX
$4.73B
$244K 0.01%
+29,036
New +$197K
IWM icon
413
iShares Russell 2000 ETF
IWM
$83.1B
$242K 0.01%
1,002
-8,160
-89% -$1.87M
USMV icon
414
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
$236K 0.01%
2,483
-145
-6% -$13.6K
MDWD icon
415
MediWound
MDWD
$183M
$236K 0.01%
13,070
LIT icon
416
Global X Lithium & Battery Tech ETF
LIT
$1.55B
$227K 0.01%
+4,000
New +$184K
XLB icon
417
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$224K 0.01%
+4,990
New +$226K
PCAP
418
CALL
ProCap Acquisition Corp
PCAP
$327M
$222K 0.01%
+329,286
New +$3.39M
ONCH
419
CALL
1RT Acquisition Corp
ONCH
$221M
$197K 0.01%
+215,625
New +$2.22M
WIX icon
420
CALL
WIX.com
WIX
$2.79B
$195K ﹤0.01%
+1,100
New +$166K
IMTX icon
421
Immatics
IMTX
$1.28B
$194K ﹤0.01%
22,788
PTON icon
422
CALL
Peloton Interactive
PTON
$2.86B
$180K ﹤0.01%
+20,000
New +$149K
ULCC icon
423
PUT
Frontier Group Holdings
ULCC
$1.86B
$155K ﹤0.01%
+35,000
New +$159K
AUPH icon
424
Aurinia Pharmaceuticals
AUPH
$1.93B
$149K ﹤0.01%
+13,500
New +$147K
OLMA icon
425
Olema Pharmaceuticals
OLMA
$1.03B
$132K ﹤0.01%
13,500

Similar funds

J. Goldman & Co's Q3 2025 Portfolio in Review

As of Q3 2025, J. Goldman & Co held 657 positions worth $3.98B, down 4.7% from $4.18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co withdrew a net $412M in Q3 2025, closing 218 positions and reducing 120 holdings. Its most notable exit was Electronic Arts, an estimated $129M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, J. Goldman & Co opened a new position in Microsoft worth $110M.

  • J. Goldman & Co's largest Q3 2025 buy was Microsoft: 212,306 shares worth $110M.
  • J. Goldman & Co added most to Meta Platforms (Facebook) in Q3 2025, an estimated $65.8M increase.
  • J. Goldman & Co's biggest Q3 2025 reduction was Amazon, cutting an estimated $79.3M.
  • J. Goldman & Co fully exited Electronic Arts in Q3 2025, selling an estimated $129M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.98B portfolio in Q3 2025.
  • J. Goldman & Co opened 219 new positions and closed 218 in Q3 2025.
  • J. Goldman & Co's portfolio value fell 4.7% quarter-over-quarter to $3.98B.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.